Antibiotics

Kefodime 50 Dt

Description

Cefpodoxime is an extended spectrum semi-synthetic antibiotic which belongs to the third generation of cephalosporins. It inhibits bacterial cell wall synthesis leading to bacterial cell death. Cefpodoxime is given as Cefpodoxime proxetil (prodrug) which is hydrolyzed in the intestinal epithelium to release active drug Cefpodoxime. It is active against broad spectrum of Gram +ve & Gram -ve bacteria. Organisms resistant to penicillins and some cephalosporins due to their b-lactamases secretion are susceptible to Cefpodoxime. It is effective for longer duration with higher clinical success rate and low incidence of side effects.

Cefpodoxime is an extended spectrum semi-synthetic antibiotic which belongs to the third generation of cephalosporins. It inhibits bacterial cell wall synthesis leading to bacterial cell death. Cefpodoxime is given as Cefpodoxime proxetil (prodrug) which is hydrolyzed in the intestinal epithelium to release active drug Cefpodoxime. It is active against broad spectrum of Gram +ve & Gram -ve bacteria. Organisms resistant to penicillins and some cephalosporins due to their b-lactamases secretion are susceptible to Cefpodoxime. It is effective for longer duration with higher clinical success rate and low incidence of side effects.

Cefpodoxime is an extended spectrum semi-synthetic antibiotic which belongs to the third generation of cephalosporins. It inhibits bacterial cell wall synthesis leading to bacterial cell death. Cefpodoxime is given as Cefpodoxime proxetil (prodrug) which is hydrolyzed in the intestinal epithelium to release active drug Cefpodoxime. It is active against broad spectrum of Gram +ve & Gram -ve bacteria. Organisms resistant to penicillins and some cephalosporins due to their b-lactamases secretion are susceptible to Cefpodoxime. It is effective for longer duration with higher clinical success rate and low incidence of side effects.

Cefpodoxime is an extended spectrum semi-synthetic antibiotic which belongs to the third generation of cephalosporins. It inhibits bacterial cell wall synthesis leading to bacterial cell death. Cefpodoxime is given as Cefpodoxime proxetil (prodrug) which is hydrolyzed in the intestinal epithelium to release active drug Cefpodoxime. It is active against broad spectrum of Gram +ve & Gram -ve bacteria. Organisms resistant to penicillins and some cephalosporins due to their b-lactamases secretion are susceptible to Cefpodoxime. It is effective for longer duration with higher clinical success rate and low incidence of side effects.

It is a combination of Cefixime (3rd generation cephalosporin) & Ofloxacin (fluoroquinolone) for the treatment of Typhoid fever, Urinary tract infection, & Respiratory tract infection. Cefixime kills bacteria by inhibiting bacterial cell wall synthesis & ofloxacin kills by affecting bacterial DNA gyrase. As both acts on different target sites provide synergistic effect against most of pathogens, also both Cefixime & Ofloxacin have been recommended by the WHO for the treatment of Typhoid.

It is a combination of Cefixime (3rd generation cephalosporin) & Ofloxacin (fluoroquinolone) for the treatment of Typhoid fever, Urinary tract infection, & Respiratory tract infection. Cefixime kills bacteria by inhibiting bacterial cell wall synthesis & ofloxacin kills by affecting bacterial DNA gyrase. As both acts on different target sites provide synergistic effect against most of pathogens, also both Cefixime & Ofloxacin have been recommended by the WHO for the treatment of Typhoid.

It is a combination of Cefixime (3rd generation cephalosporin) & Ofloxacin (fluoroquinolone) for the treatment of Typhoid fever, Urinary tract infection, & Respiratory tract infection. Cefixime kills bacteria by inhibiting bacterial cell wall synthesis & ofloxacin kills by affecting bacterial DNA gyrase. As both acts on different target sites provide synergistic effect against most of pathogens, moreover both Cefixime & Ofloxacin have been recommended by the WHO for the treatment of Typhoid.